GSA Capital Partners’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,417	Closed	-$221K	–	2152
2025 Q4	$221K	Sell	7,417 -3,478	-32%	-$114K	0.02%	1348
2025 Q3	$394K	Buy	+10,895	New	+$359K	0.03%	1017
2025 Q2	–	Sell	-5,680	Closed	-$224K	–	2143
2025 Q1	$224K	Buy	+5,680	New	+$191K	0.02%	1340
2024 Q4	–	Sell	-10,987	Closed	-$257K	–	2029
2024 Q3	$257K	Sell	10,987 -13,465	-55%	-$294K	0.02%	1302
2024 Q2	$435K	Buy	+24,452	New	+$390K	0.03%	1053
2023 Q4	–	Sell	-22,857	Closed	-$191K	–	1923
2023 Q3	$191K	Sell	22,857 -48,661	-68%	-$678K	0.02%	1293
2023 Q2	$1.78M	Buy	71,518 +38,107	+114%	+$984K	0.18%	86
2023 Q1	$503K	Sell	33,411 -98,482	-75%	-$1.5M	0.05%	718
2022 Q4	$1.56M	Buy	131,893 +92,427	+234%	+$671K	0.19%	57
2022 Q3	$234K	Sell	39,466 -5,815	-13%	-$38.1K	0.03%	1109
2022 Q2	$192K	Sell	45,281 -17,903	-28%	-$112K	0.03%	1082
2022 Q1	$601K	Buy	63,184 +52,440	+488%	+$607K	0.08%	422
2021 Q4	$204K	Buy	+10,744	New	+$279K	0.03%	1217
2021 Q1	–	Sell	-6,442	Closed	-$335K	–	1490
2020 Q4	$335K	Buy	+6,442	New	+$218K	0.05%	678
2019 Q4	–	Sell	-61,115	Closed	-$343K	–	1726
2019 Q3	$343K	Buy	+61,115	New	+$426K	0.05%	799